Men taking statins are 24% less likely to experience lethal prostate cancer.. Researchers believe that low cholesterol keeps tumors from rapid growth.

If men take statins, then their risk of developing the deadliest form of prostate cancer is reduced by 24%, according to a study by scientists from Ireland. They watched over 44,000 British men for more than two decades. Some men took cholesterol-lowering drugs. The total prevalence of prostate tumors in all groups of men was approximately the same, regardless of whether they took statins or not..

However, these drugs have been shown to protect against a more aggressive and incurable form of prostate cancer, known as the PTEN-zero tumor (PTEN, a tumor suppressing protein). Usually, this cancer spreads rapidly to other organs, i.e., metastasizes..

The authors of the study suggested that this is due to the ability of statins to reduce inflammatory processes and increase the immune level in the prostate gland..

The results of this study support the findings of other scientific studies that have shown that patients receiving statins are less likely to die from cancer. But this study was the first to specifically examine the effects of drugs on the development of various forms of prostate cancer.. Research Results Published by Clinical Cancer Research.

https: // www. medikforum. ru /.

Keywords:.